Epilepsy

(redirected from refractory epilepsy)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

EPILEPSY, med. jur. A disease of the brain, which occurs in paroxysms, with uncertain intervals between them.
     2. These paroxysms are characterized by the loss of sensation, and convulsive motions of the muscles. When long continued and violent, this disease is very apt to end in dementia. (q.v.) It gradually destroys the memory, and impairs the intellect, and is one of the causes of an unsound mind. 8 Ves. 87. Vide Dig. 50, 16, 123; Id. 21, 1, 4, 5.

References in periodicals archive ?
Pediatric patients with chronic medically refractory epilepsy are affected with different pathology compared to patients with new-onset seizures and require specialized imaging.
Smolowitz performed a retrospective review of 213 patients to determine in part if EMU admission resulted in change in diagnosis or treatment in patients with medically refractory epilepsy.
Persons with epilepsy and their families should feel comfortable in considering the use of VNS therapy as a treatment option in refractory epilepsy.
The FitNeS system was developed to offer a new treatment option for refractory epilepsy patients while delivering improvements over existing vagus nerve stimulation devices.
Researchers from the University of Missouri--Kansas City (UMKC), for example, reported that adhering to a ketogenic diet (KGD) reduced the number of emergency department visits and hospitalizations, and decreased the length of epilepsy-related hospital stays in children with pharmacologically refractory epilepsy.
Comment: The ketogenic diet is an effective treatment for refractory epilepsy in children, but it is has not been well studied in adults.
Ring chromosome 20 syndrome is a chromosome disorder that causes refractory epilepsy, the most difficult type of epilepsy to treat.
Forty-four of 67 children (66%) had nonrefractory epilepsy, 20 of 67 had refractory epilepsy (30%), and 3 of 67 (4%) had newly diagnosed epilepsy (less than 6 months since diagnosis).
This study will evaluate the compound as an add-on therapy in patients with refractory epilepsy for its safety and tolerability as well as provide a preliminary assessment of its effectiveness for seizures and its actions on mood and memory.
NYSE: MDT) today announced that it has received from Health Canada a license for Medtronic Deep Brain Stimulation (DBS) Therapy for refractory epilepsy patients.
The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of medically refractory epilepsy and treatment-resistant depression.
Delivery of the vagus nerve stimulators for the treatment of refractory epilepsy.